BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 15370706)

  • 1. Anetodermic lupus panniculitis and antiphospholipid antibodies: report of three cases.
    Marzano A; Vanotti M; Alessi E
    Acta Derm Venereol; 2004; 84(5):385-8. PubMed ID: 15370706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerodermic linear lupus panniculitis: report of two cases.
    Marzano AV; Tanzi C; Caputo R; Alessi E
    Dermatology; 2005; 210(4):329-32. PubMed ID: 15942222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anetodermic primary cutaneous B-cell lymphoma: a unique clinicopathological presentation of lymphoma possibly associated with antiphospholipid antibodies.
    Hodak E; Feuerman H; Barzilai A; David M; Cerroni L; Feinmesser M
    Arch Dermatol; 2010 Feb; 146(2):175-82. PubMed ID: 20157029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anetoderma during antiphospholipid syndrome. 3 cases].
    Disdier P; Christides C; Andrac-Meyer L; Rojat-Habib MC; Aillaud MF; Swiader L; Weiller-Merli C; Berbis P; Harlé JR; Weiller PJ
    Ann Dermatol Venereol; 1996; 123(12):800-3. PubMed ID: 9636765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary anetoderma: a cutaneous marker of antiphospholipid antibodies.
    Staiger H; Saposnik M; Spiner RE; Schroh RG; Corbella MC; Hassan ML
    Skinmed; 2011; 9(3):168-71. PubMed ID: 21675496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical entity of Lupus erythematosus panniculitis/lupus erythematosus profundus.
    Arai S; Katsuoka K
    Autoimmun Rev; 2009 May; 8(6):449-52. PubMed ID: 19162248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupus panniculitis: clinical perspectives from a case series.
    Martens PB; Moder KG; Ahmed I
    J Rheumatol; 1999 Jan; 26(1):68-72. PubMed ID: 9918242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Panniculitis-fasciitis syndrome disclosing systemic erythematous lupus].
    Carsuzaa F; Pierre C; De Jaureguiberry JP; Marlier S; Morand JJ; Marrot F
    Ann Dermatol Venereol; 1996; 123(4):259-61. PubMed ID: 8763750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facets of lupus erythematosus: panniculitis responding to thalidomide.
    Wienert S; Gadola S; Hunziker T
    J Dtsch Dermatol Ges; 2008 Mar; 6(3):214-6. PubMed ID: 18076656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of panniculitis and haemophagocytic syndrome in a patient with chronic systemic lupus erythematosus.
    Deji N; Sugimoto T; Fujimoto T; Aoyama M; Takeda N; Sakaguchi M; Uzu T; Kashiwagi A
    Lupus; 2007; 16(5):363-5. PubMed ID: 17576740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periparotid lupus erythematosus panniculitis. Clinicopathologic correlation of two cases presenting as primary parotid disease.
    White WL; Sherertz EF; Berg D; Clark RE
    Arch Pathol Lab Med; 1993 May; 117(5):535-9. PubMed ID: 8489346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Coronary involvement in systemic lupus erythematosus].
    Lair G; Joly P; Desrumeaux G; Thomine E; Godin M; Tron F; Letac B; Lauret P
    Ann Dermatol Venereol; 1997; 124(8):534-6. PubMed ID: 9740846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lupus erythematosus panniculitis (lupus profundus): clinical, histopathological, and molecular analysis of nine cases.
    Massone C; Kodama K; Salmhofer W; Abe R; Shimizu H; Parodi A; Kerl H; Cerroni L
    J Cutan Pathol; 2005 Jul; 32(6):396-404. PubMed ID: 15953372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous lupus erythematosus: a personal approach to management.
    Callen JP
    Australas J Dermatol; 2006 Feb; 47(1):13-27. PubMed ID: 16405478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Borderline systemic lupus erythematosus (SLE): a separate entity or a forerunner to SLE?
    Al Attia HM
    Int J Dermatol; 2006 Apr; 45(4):366-9. PubMed ID: 16650159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies.
    Reiner P; Galanaud D; Leroux G; Vidailhet M; Haroche J; Huong du LT; Francès C; Papo T; de Gennes C; Musset L; Wechsler B; Amoura Z; Piette JC; Costedoat-Chalumeau N
    Mov Disord; 2011 Nov; 26(13):2422-7. PubMed ID: 21755538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is the primary antiphospholipid syndrome a forerunner of SLE?].
    Tarr T; Muzes G; Pitlik E; Lakos G; Csépány T; Soltész P; Zeher M; Szegedi G; Kiss E
    Orv Hetil; 2005 Jan; 146(5):203-7. PubMed ID: 15773587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.
    Cheunsuchon B; Rungkaew P; Chawanasuntorapoj R; Pattaragarn A; Parichatikanond P
    Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroencephalography in the assessment of neuropsychiatric manifestations in antiphospholipid syndrome and systemic lupus erythematosus.
    Lampropoulos CE; Koutroumanidis M; Reynolds PP; Manidakis I; Hughes GR; D'Cruz DP
    Arthritis Rheum; 2005 Mar; 52(3):841-6. PubMed ID: 15751063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.